| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1738c007df5351eb10e242ad8fa744a4 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-425
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D513-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D513-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-425 |
| filingDate |
1976-10-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1979-01-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f8933ba88c1508417019a8c8cb379ccc |
| publicationDate |
1979-01-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-4137320-A |
| titleOfInvention |
Pharmaceutical compositions containing imidazo(2,1-b)thiazoles and process for reducing blood sugar levels therewith |
| abstract |
Pharmaceutical compositions containing certain imidazo(2,1-b)thiazoles, their physiologically acceptable acid addition- or quaternary ammonium salts, and a process for reducing blood sugar levels by the administration thereof. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10385069-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5019572-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011144011-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012082921-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003013657-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6900218-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6037469-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8394766-B2 |
| priorityDate |
1974-02-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |